Log in to search using one of your social media accounts:

 

Can CME Help the Opioid Epidemic?

Conclusion Therefore, POLITICO and the stakeholders made a policy recommendation focused on educating providers. They suggest that education on both pain management and addiction has to start in medical school. However, early education is not enough unless it is supplemented by CME. The medical field should continue the progress it has made increasing education around proper prescribing, but it should increase its efforts by evaluating doctors in some meaningful way such as on licensing exams or through CME.       Related StoriesACCME Introduces Guidance for CME Providers in Europe and AsiaUrine Testing: The Next Shoe to Drop?Senate HELP Committee Holds Hearing on Opioid Response 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs

Related Links:

The widespread U.S. opioid &overdose crisis is an ever-increasing tragic concern for everyone: writhing victims, family members being fain to see their relatives suffer or die, doctors prescribing opioid pain-killers what they thought before as safe, and regulators imposed to handle a tough situation. Addiction. It’s painful to even read about the skyrocketing numbers of people suffering, thus we decided to map how digital health could help tackle the opioid crisis. Why is it so difficult to deal with the opioid crisis? Once you become addicted, it sticks with you for a long time, if not for life, just as a ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Bioethics Mobile Health Virtual Reality in Medicine AI artificial intelligence data data analytics drugs future gc3 Innovation opioid opioid crisis pharma technology wearables Source Type: blogs
In 2015, the opioid crisis was escalating to emergency-level proportions, claiming as many lives as car accidents. As the daughter of a longtime drug addict, the current burgeoning opioid epidemic managed to be both familiar and strange to me at the same time. My mother developed her addictions during the height of drug epidemics that occurred in New York City in the mid-1980s. The timeframe also marked the infancy of the AIDS crisis and the height of Reagan-era “Just Say No” programs. Back then, addiction was treated and viewed more as a crime than a disease, supposedly committed by scoundrels and misfits. The...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Addiction Behavioral Health Source Type: blogs
By DAVID HARLOW, MD The opioid crisis has been upon us for years now, and we are now seeing the problem become more pervasive, with more than 90 deaths per day in the U.S. due to this scourge. The president recently said he would be declaring a public health emergency (which would free up some funds) but has not done so as of this writing. The public health threat is so persistent that it calls for responses on many levels, and those responses are coming. Some have been in place for a while, some are more recent. These responses may be broken down into a number of different categories: Broader availability of naloxone (an...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Charlie Baker Harlow Internet Massachussetts Opioid Opioid crisis Source Type: blogs
Opioids are frequently prescribed for chronic pain. For the past 2 decades, long-term opioid analgesic therapy was considered the cornerstone of effective pain management for chronic nonmalignant conditions, despite a lack of documented effectiveness and safety, with the attendant risk of addiction, overdose, and death. Cognitive behavioral therapy (CBT) may be used effectively to treat chronic pain, either as a stand-alone treatment or with other nonopioid pharmacological treatments. CBT improves pain-related outcomes along with mobility, quality of life, and disability and mood outcomes. Compared with long-term use of op...
Source: Journal of Psychiatric Practice - Category: Psychiatry Tags: Articles Source Type: research
Discussion Senator Chris Murphy highlighted that Dr. Katz is the first Assistant Secretary for Mental Health and Substance Use at SAMHSA, a new position created under the 21st Century Cures Act. She detailed for the committee the many activities SAMHSA is overseeing to implement the CARA and 21st Century Cures Act, including administering a wide range of grant streams aimed at mental health interventions and the proliferation of medication assisted treatment. She emphasized to the lawmakers the importance of greater integration of mental health and substance abuse treatment into primary care, and better training among a w...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs
Senate Finance Committee Chairman Orrin Hatch, along with 10 of his Republican Committee colleagues, recently called on the Department of Health and Human Services (HHS) to increase safeguards against opioid fraud. In the letter, the senators request information about HHS’ measures to prevent opioid abuse among Medicare Part D providers and beneficiaries. The letter requests details regarding the HHS Office of Inspector General’s (OIG) report issued last July, which found that one in three Medicare Part D beneficiaries received a prescription opioid in 2016 – as many as 500,000 of those beneficiaries wer...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs
I have blogged previously about the role of PBMs in shipping drugs to retail drug stores that placed suspiciously high drug orders (see:Drug Distributor McKesson Pays Record Penalty For Suspicious Opioid Orders). The role of the Sackler family, owners ofPurdue Pharma, in aggressively pushing Oxycontin is also now coming to light (see:The Sackler Family: best known for philanthropy, they made billions promoting Oxycontin;Report: Stamford company confirms DOJ probe). Let's face facts. You can't have a country-wide epidemic of prescription drugs without the connivance of some of the major corporations. Some of th...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Healthcare Business Medical Ethics Pharmaceutical Industry Source Type: blogs
Abstract An overreliance on opioids has impacted all types of pain management, making it undoubtedly a root cause of the "epidemic" of prescription opioid abuse in the United States. Yet, an examination of the statistics that led the US Centers for Disease Control and Prevention to declare that prescription opioid abuse had reached epidemic levels shows that the abuse occurrences and deaths are arising outside the hospital or hospice setting, which strongly implicates the outpatient use of opioids to treat chronic pain. Such abuse and related deaths are occurring in chronic pain patients themselves and a...
Source: Anesthesia and Analgesia - Category: Anesthesiology Authors: Tags: Anesth Analg Source Type: research
Abstract As the United States experiences an epidemic of prescription drug abuse, and guidelines on safe practices in prescribing opioids in chronic pain have subsequently emerged from professional organizations and governmental agencies, limited guidance exists for prescribers of opioids to treat pain in patients with cancer or terminal illness. Patients with active cancer or terminal illness often have pain and are frequently prescribed opioids and other controlled substances. Current studies suggest that patients with cancer have similar rates of risk for misuse, abuse, and addiction as the general public. More...
Source: Anesthesia and Analgesia - Category: Anesthesiology Authors: Tags: Anesth Analg Source Type: research
A coalition of 41 states' attorneys general have served five major opioid manufacturers with subpoenas seeking information about how these companies marketed and sold prescription opioids. The coalition is also demanding documents and information related to distribution practices from three drug distributors. The investigative subpoenas and document requests were sent to pharmaceutical manufacturers Endo International, Janssen Pharmaceuticals, Teva Pharmaceutical Industries Ltd./Cephalon Inc. and Allergan. The group also served a supplemental investigative subpoena to Purdue Pharma. Documents were also requested of three ...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs
More News: Addiction | American Health | Chronic Pain | Continuing Medical Education | Education | Emergency Medicine | Environmental Health | Epidemics | Epidemiology | Health Management | International Medicine & Public Health | Legislation | Lessons | Nurses | Nursing | Pain | Pain Management | Politics | Teaching | Training | Trump | Universities & Medical Training | USA Health